Characterization of Adherent Bacteroidales from Intestinal Biopsies of Children and Young Adults with Inflammatory Bowel Disease

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Zitomersky, Naamah L ^a   Atkinson, Benjamin J ^a   Franklin, Sarah W ^a   Mitchell, Paul D ^a   Snapper, Scott B ^a,b   Comstock, Laurie E ^b   Bousvaros, Athos ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; DNA 16S; ENTEROTOXIN; MUCIN; POLYSACCHARIDE A; RNA 16S; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTEROIDALES; BFT GENE; CARBOHYDRATE SYNTHESIS; CARBON SOURCE; CHILD; CONTROLLED STUDY; CROHN DISEASE; DNA SEQUENCE; ENTERITIS; FEMALE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; SPECIES DIVERSITY; SPECIES IDENTIFICATION; ULCERATIVE COLITIS;

ADOLESCENT; BACTEROIDES FRAGILIS; BACTEROIDETES; BIOPSY; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MALE; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

BACTERIA (MICROORGANISMS); BACTEROIDALES; BACTEROIDES FRAGILIS; MURINAE;

EID: 84878911418     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063686     Document Type: Article

References (54)

1. Xavier RJ, Podolsky DK, (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
2. Harper PH, Lee EC, Kettlewell MG, Bennett MK, Jewell DP, (1985) Role of the faecal stream in the maintenance of Crohn's colitis. Gut 26: 279-284.
3. Rutgeerts P, Hiele M, Geboes K, Peeters M, Penninckx F, et al. (1995) Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108: 1617-1621.
4. Khan KJ, Ullman TA, Ford AC, Abreu MT, Abadir A, et al. (2011) Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 106: 661-673.
5. Eckburg PBBE, Bernstein CN, Sargent M, Purdom EA, Relman DA, (2005) Molecular analysis of the colonic mucosal microbiota in patients with Crohn's disease. Science 308: 1635-1638.
6. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, et al. (2002) Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68: 3401-3407.
7. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ, (2006) Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 44: 4136-4141.
8. Lucke K, Miehlke S, Jacobs E, Schuppler M, (2006) Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J Med Microbiol 55: 617-624.
9. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, et al. (2011) High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 11: 7.
10. Rehman A, Lepage P, Nolte A, Hellmig S, Schreiber S, et al. (2010) Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol 59: 1114-1122.
11. Comelli EM, Simmering R, Faure M, Donnicola D, Mansourian R, et al. (2008) Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota. Genomics 91: 70-77.
12. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL, (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122: 107-118.
13. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, et al. (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291: 881-884.
14. Mazmanian SK, Round JL, Kasper DL, (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453: 620-625.
15. Coyne MJ, Tzianabos AO, Mallory BC, Carey VJ, Kasper DL, et al. (2001) Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis. Infect Immun 69: 4342-4350.
16. Rhee KJ, Wu S, Wu X, Huso DL, Karim B, et al. (2009) Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun 77: 1708-1718.
17. Nell S, Suerbaum S, Josenhans C, (2010) The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 8: 564-577.
18. Rath HC, Wilson KH, Sartor RB, (1999) Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 67: 2969-2974.
19. Hoentjen F, Harmsen HJ, Braat H, Torrice CD, Mann BA, et al. (2003) Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice. Gut 52: 1721-1727.
20. Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, et al. (2011) Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9: 390-403.
21. Malaty HM, Fan X, Opekun AR, Thibodeaux C, Ferry GD, (2010) Rising incidence of inflammatory bowel disease among children: a 12-year study. J Pediatr Gastroenterol Nutr 50: 27-31.
22. Conte MP, Schippa S, Zamboni I, Penta M, Chiarini F, et al. (2006) Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 55: 1760-1767.
23. Kellermayer R, Mir SA, Nagy-Szakal D, Cox SB, Dowd SE, et al. (2012) Microbiota separation and C-reactive protein elevation in treatment-naive pediatric granulomatous Crohn disease. J Pediatr Gastroenterol Nutr 55: 243-250.
24. Png CW, Linden SK, Gilshenan KS, Zoetendal EG, McSweeney CS, et al. (2010) Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105: 2420-2428.
25. Satsangi J, Silverberg MS, Vermeire S, Colombel JF, (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55: 749-753.
26. Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, et al. (2007) Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 133: 423-432.
27. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, et al. (1991) Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12: 439-447.
28. Liu C, Song Y, McTeague M, Vu AW, Wexler H, et al. (2003) Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. FEMS Microbiol Lett 222: 9-16.
29. Chung GT, Franco AA, Wu S, Rhie GE, Cheng R, et al. (1999) Identification of a third metalloprotease toxin gene in extraintestinal isolates of Bacteroides fragilis. Infect Immun 67: 4945-4949.
30. Varel VH, Bryant MP, (1974) Nutritional features of Bacteroides fragilis subsp. fragilis. Appl Microbiol 28: 251-257.
31. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, et al. (2009) Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42: 377-381.
32. Swidsinski A, Loening-Baucke V, Bengmark S, Lochs H, Dorffel Y, (2007) Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis. Inflamm Bowel Dis 13: 51-56.
33. Sears CL (2009) Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev 22: 349-369, Table of Contents.
34. Krinos CM, Coyne MJ, Weinacht KG, Tzianabos AO, Kasper DL, et al. (2001) Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 414: 555-558.
35. Pantosti A, Colangeli R, Tzianabos AO, Kasper DL, (1995) Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates. J Clin Microbiol 33: 2647-2652.
36. Comstock LE, Pantosti A, Kasper DL, (2000) Genetic diversity of the capsular polysaccharide C biosynthesis region of Bacteroides fragilis. Infect Immun 68: 6182-6188.
37. Neut C, Bulois P, Desreumaux P, Membre JM, Lederman E, et al. (2002) Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol 97: 939-946.
38. Prindiville TP, Sheikh RA, Cohen SH, Tang YJ, Cantrell MC, et al. (2000) Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg Infect Dis 6: 171-174.
39. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI, (2003) Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4: 269-273.
40. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104: 13780-13785.
41. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, et al. (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53: 685-693.
42. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H, (2005) Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43: 3380-3389.
43. Gosiewski T, Strus M, Fyderek K, Kowalska-Duplaga K, Wedrychowicz A, et al. (2012) Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 54: 20-27.
44. Verma R, Verma AK, Ahuja V, Paul J, (2010) Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India. J Clin Microbiol 48: 4279-4282.
45. Peterson DA, McNulty NP, Guruge JL, Gordon JI, (2007) IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2: 328-339.
46. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
47. Zitomersky NL, Coyne MJ, Comstock LE, (2011) Longitudinal Analysis of the Prevalence, Maintenance, and IgAResponse to Bacteroidales Species of the Human Gut. Infect Immun 79: 2012-2020.
48. Papa E, Docktor M, Smillie C, Weber S, Preheim SP, et al. (2012) Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One 7: e39242.
49. Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, et al. (2011) Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 163: 250-259.
50. Tsai HH, Sunderland D, Gibson GR, Hart CA, Rhodes JM, (1992) A novel mucin sulphatase from human faeces: its identification, purification and characterization. Clin Sci (Lond) 82: 447-454.
51. Sheng YH, Hasnain SZ, Florin TH, McGuckin MA, (2011) Mucins in inflammatory bowel diseases and colorectal cancer. J Gastroenterol Hepatol 27: 28-38.
52. Basset C, Holton J, Bazeos A, Vaira D, Bloom S, (2004) Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci 49: 1425-1432.
53. Chatzidaki-Livanis M, Weinacht KG, Comstock LE, (2010) Trans locus inhibitors limit concomitant polysaccharide synthesis in the human gut symbiont Bacteroides fragilis. Proc Natl Acad Sci U S A 107: 11976-11980.
54. Kaufman J, Griffiths TA, Surette MG, Ness S, Rioux KP, (2009) Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression. Inflamm Bowel Dis 15: 985-996.